| Quick Links |
|---|
Since the importance of a well-balanced gut microflora for adequate health and high performance has been recognised, feeding strategies have been directed to control the microbial gastrointestinal environment by nutritional means. Especially the use of probiotics has been shown to be an effective means of manipulating or managing the composition of the microbial population in the gastrointestinal tract of animals to achieve or reestablish the state of Eubiosis. Intake of probiotics should result in the creation of gut microecology conditions that suppress harmful microorganisms and favour beneficial microorganisms, and ultimately enhance gut health. This is also necessary for a well-functioning and effective digestion of nutrients, resulting in good growth performance. Besides nutrient absorption, the intestine plays an important role as the biggest immune organ of the body. It is hence part of the body‘s defense system and represents an important barrier against invading pathogens.
The scientific community is changing its way to look at the mode of actions of probiotics. Since probiotics have been commercially available they have been expected to exert their benefits derived from their ability to multiply, produce certain metabolites and colonize the surface of the intestinal epithelium. Today (and since the last 10 years) researchers are challenging the “classic” mode of actions of probiotics with novel ones. So far there is a good bulk of evidence suggesting that some of the effects of probiotics like the anti-inflammatory effect are mediated by fingerprints (structural molecules) rather than by the whole organisms or their ability to colonize the intestine. So also in case probiotics are partly inactivated in the course of feed processing or antibiotic treatment at therapeutic doses there are beneficial mechanism which do not depend on live bacteria and which will remain unaltered. As long as the effector molecules within the probiotics remain with the appropriate structure a biological effect should be expected. Commonly used probiotic bacteria in animal feeding are lactic acid producing strains like Enterococcus, Pediococcus, Lactobacillus and Bifidobacterium which are also genera which are commonly found in the poultry gut. In several scientific studies it was shown that they have a beneficial effect on performance, pathogen inhibition, modulation of intestinal microflora and immuno-modulation. Especially during critical times in the production cycle when a protective gut microflora is not yet established or disrupted probiotic application exerts its benefits.
Under normal conditions (i.e. in the wild), animals pick up their microflora from adult animals and from the environment very quickly, but under conditions of modern animal production, things are different. Commercial broiler chicks hatch in extremely clean conditions and don’t have contact with adult animals. Then they are transferred in houses previously cleaned and disinfected. For them, to build up and establish a well-balanced microflora is difficult. During that time, the chicks are not protected against the colonization with pathogenic microbes. For the chicks it is crucial to develop a protecting microflora as early and fast as possible, which can be supported by the application of probiotics. Probiotic products can be sprayed onto the chicks already in the hatchery or be applied via the drinking water during the first days of life. They provide conditions in the chicks intestine that favour the colonization by beneficial microbes.
Antibiotics are useful tools to eliminate undesired pathogens. However, they also eliminate a large proportion of the beneficial microflora which needs to be re-established after the antibiotic treatments ends to avoid fast growth of opportunistic pathogens. Antibiotics may eliminate the pathogens but they often do not sufficiently control inflammation. In many cases of pathogenic invasion an exaggerated response of the immune system may cause even more damage than the pathogen itself. Probiotics can help modulating the immune system It is very common in the field to see the severe inflammation of the intestinal mucosa regardless of the ongoing antibiotic therapy. Intestinal inflammation is related to increased velocity of the intestinal content. As a consequence, feces with increased amount of humidity, gas, excess of indigested feed particles or fragments of intestinal mucosa may be a common finding derived from intestinal inflammation. Confirmation of intestinal inflammation can be obtained from necropsied animals. The use of probiotics is recommended to fight side effects of diseases that will not be improved by the use of antibiotics. In this scenario, antibiotics in therapeutic doses should be taking care of pathogens; however, the intestinal inflammation often remains unattended. Even inactivated probiotics exert a beneficial effect reducing inflammation by means of their cellular structure and particularly their intact DNA molecules and receptors which are unique to every probiotic strain.
Necrotic enteritis is one of the world’s most common and financially crippling poultry diseases which when triggered, can cause mortality rates of up to 50%. A team of USDA research scientist has investigated if the use of a multi-species probiotic may be beneficial in the control of poultry diseases which are related to Clostridium perfringens. In conclusion the data of these studies suggest that the probiotic was able to control poultry diseases like Necrotic enteritis and Gangrenous dermatitis.
The use of probiotic products can provide the poultry industry with an alternative management tool that has the potential to promote better intestinal health by managing the composition of the microbial population in the gastrointestinal tract and thus protecting poultry flocks from infections with pathogenic bacteria and decrease monetary losses due to pathogens.
![]() |
Mycotoxins in aquaculture Read the new issue of the BIOMIN Newsletter |
![]() |
New on the Mycotoxin Channel Barbara Daxner (Lab Manager, Romer Labs®, Tulln, Austria) answers the question:... |
![]() |
BIOMIN Mycotoxin Survey Program 2011 Read the new issue of the BIOMIN Newsletter |
![]() |
TECHAGRO 2012 From March 31st – April 4th BIOMIN Czech exhibited at the International Fair of... |